Jessica Boggia

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients.

APG Asset Management US, Inc. (APG US) is a SEC-registered investment advisor and pension fund manager headquartered in New York City. The firm was founded in 1998 and is a subsidiary of APG Asset Management NV (APG NL), ultimately held by Stichting Pensioenfonds ABP, the pension fund for Dutch government employees and other civil service employees. APG US provides investment advisory services to ABP and other Dutch pension funds directly and/or through the Dutch pension funds’ participation in various “fondsen voor gemene rekening” (funds for the joint account of the participants and referred to herein as, “FGRs”) sponsored and controlled by APG NL.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands.

AlpInvest Partners, Inc. (AlpInvest) is the New York City private equity subsidiary of Netherlands-based AlpInvest Partners BV, ultimately held by The Carlyle Group LP (NASDAQ: CG). Established in 1999 as NIB Capital Private Equity, the firm became AlpInvest Partners in 2004. They were the first exclusive private equity manager for a public pension fund and invest worldwide across primary funds, secondaries, and direct investment (co-investment) channels, covering the entire private equity spectrum. In addition to the New York office, AlpInvest has offices in Amsterdam, Hong Kong and London. They are a socially responsible investor which works to promote sustainability and governance as an important factor in investment choices. They are a signatory to the UN Principles for Responsible Investments and exclude direct investments in companies that are directly involved in the manufacturing or distribution of products that clearly violate Dutch and relevant international conventions. They also explore sustainability-themed investments.

Signature Foods Belgium NV produces and distributes salads. The company was founded by Celis M Herman in 1962 and is headquartered in Turnhout, Belgium.

Doedijns Group International BV engages in the production and distribution of mission critical engineered hydraulic and pneumatic solutions to oil and gas and maritime industries. It offers ballast control systems, coiled tubing lift frames, cylinders emergency shut down systems, helicopter refueling systems, hydraulic power units, manifolds, scissors lifts, winch systems, launch and recovery systems, upending control systems, and well head control panels. The company was founded in 1879 and is headquartered in Leidschendam, the Netherlands.

Vitruvian Partners LLP (Vitruvian Partners) is a private equity firm founded in 2006 by Ian Riley, Michael Risman, Toby Wyles, Mark Harford and David Nahama. The firm is headquartered London, the United Kingdom with offices across the globe.

Ondal Medical Systems GmbH designs, develops and manufactures medical equipment. It offers lighting systems, monitor suspension systems for imaging processes, x-ray protection systems, video systems and supply systems for surgery, endoscopy, anesthesia, intensive care unit, and industrial applications. The company was founded in 1945 and is headquartered in Hünfeld, Germany.

Part of WPP Plc, Ogilvy & Mather Advertising, Inc. is a company that provides advertising services. The company is based in New York, NY. Devika Bulchandani has been the CEO of the company since 2022.

AIMM Therapeutics BV develops therapeutic antibodies for the treatment of cancer and infectious diseases. Its antibody discovery platform couples proprietary knowledge of B cell immortalization with the isolation of antibodies from humans or animals. The company was founded by Donald Kalff and Hergen Spits in 2004 and is headquartered in Amsterdam, the Netherlands.

ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.

Nomios Netherlands BV engages in the supply, implementation, and maintenance of next generation networks. It offers consultancy, integration- and managed services for Next Generation Networks. The firm also provides leasing and financial services for network infrastructures. The company was founded by Leon de Keijzer in 2005 and is headquartered in Leiden, the Netherlands.

Ampelmann Operations BV provides construction and rental of offshore access solutions. Its services include operations control center, software performance, marine operation support, and maintenance. The company was founded by Jan van der Tempel in 2008 and is headquartered in Delft, the Netherlands.

Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.

MeiraGTx Netherlands BV operates as a biopharmaceutical company developing local gene therapy for inflammatory diseases. It is into develop adeno-associated viral mediated gene therapy for patients with rheumatic conditions. The company was founded in 2005 and is headquartered in Amsterdam, the Netherlands.

Het Langeland Ziekenhuis, now known as Haga Hospital Zoetermeer, is a hospital located in Zoetermeer, NL. Patients can access repeat prescriptions, leaflets, and log in to the patient portal, My Langeland, through the Haga Hospital Zoetermeer website. The hospital was renamed after merging with Haga Hospital in The Hague. The hospital's outpatient clinics and blood collection locations are closed on holidays, but the emergency department and GP station remain open. Haga Hospital is currently investigating the future of birth care in Zoetermeer. The hospital also hosts information evenings on breastfeeding and prostate health.

Optimum Group BV operates as a financial holding company with activities within the commercial printing industry. The company was founded in 2016 and is headquartered in Alkmaar, the Netherlands.

Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy.

Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom.

Citryll BV is a private pharmaceutical company located in Oss, the Netherlands, at the Pivot Park. Citryll is dedicated to developing and commercializing therapeutics that target netosis and NETs, with a focus on immune-mediated inflammatory diseases. The Dutch company's lead antibody, Cit-013, has a unique dual mode of action and proprietary NET biomarker assays, making it a promising drug for rheumatoid arthritis and hidradenitis suppurativa. The initial clinical trials with Cit-013 are expected to provide the foundation for a new treatment paradigm for immune-mediated inflammatory diseases. The company was founded in 2015 by Helmuth van Es, Renato Chirivi, and the late Jos Raats of ModiQuest.

Innov AD NV supplies animal health and nutrition solutions. It offer products such as Aflorin LIVA L, Aflonrin P L, Cerebra S, Cibus, ConSept CF60, Escent L, Escent S, Fibramax, Lumance, Lumance L, Magnet, Maxilys, Mells, Novichol, Novicid, Novigest, Novimet, Novimoid, Novinat FF, Novinox, Novion S L, Novioro, Novipra N440C, Novitech MN, Novyrate, Novyrate Calf, Novyrate Piglet, Tastemaster, Tasty Attract, Vitallite Energy Chick, Vitallite Energy Piglet, and Vitallite Supplements. The company was founded by Jamal Al Saifi and is headquartered in Essen, Belguim.

Innovad Group II BV is a Belgian company that specializes in providing species-specific solutions and products for the poultry and pig production industry. The private company is based in Antwerp, Belgium. The company focuses on improving animal health and increasing the nutritional value of feed to enhance animal performance. The company was founded in 2021, and Benoit Letor has been the CEO of the company since 2021.